The Trocar Market is projected to grow at a CAGR of 5.7% from 2024 to 2031. The market value is expected to increase from YY USD in 2024 to YY USD by 2031. North America currently dominates the market, with the highest market share and revenue. Key metrics include increasing adoption of minimally invasive surgical procedures, technological advancements in trocar design, and the growing prevalence of chronic diseases requiring surgical interventions.
The market is experiencing significant growth due to the rising demand for laparoscopic surgeries and other minimally invasive procedures globally. Trocars play a crucial role in these procedures by providing access ports for surgical instruments, driving their adoption in healthcare settings. The increasing geriatric population, advancements in healthcare infrastructure, and the growing demand for cosmetic surgeries are also contributing to market expansion.
Market Trend: Shift towards single-port laparoscopic surgery
The increasing adoption of single-port laparoscopic surgery is a significant trend driving the trocars market. Single-port laparoscopy, also known as single-incision laparoscopic surgery (SILS), involves performing minimally invasive procedures through a single incision, typically in the navel. This approach offers several advantages over traditional multi-port laparoscopy, including reduced postoperative pain, improved cosmetic outcomes, and potentially faster recovery times.
The shift towards single-port procedures has led to the development of specialised trocars designed to accommodate multiple instruments through a single access point. Manufacturers are focussing on creating innovative trocar systems that allow for the insertion of several instruments through a single incision while maintaining adequate triangulation and instrument manoeuvrability.
This trend is supported by growing clinical evidence demonstrating the safety and efficacy of single-port procedures in various surgical applications. As surgeons become more experienced with this technique and patient demand for less invasive options increasing, the market for specialised single-port trocars is expected to expand significantly.
Market Driver: Increasing prevalence of chronic diseases and rising demand for minimally invasive surgical procedures
The rising prevalence of chronic diseases that require surgical interventions is a primary driver for the trocars market. Conditions such as obesity, cardiovascular diseases, and various cancers often necessitate surgical treatments, many of which can be performed using minimally invasive techniques that rely on trocars for access.
According to the World Health Organisation, chronic diseases are responsible for 71% of all deaths globally, with cardiovascular diseases, cancer, and respiratory diseases being the leading causes. This high disease burden has led to an increased number of surgical procedures being performed worldwide, many of which utilise laparoscopic techniques.
The demand for minimally invasive procedures has grown significantly due to their numerous advantages over open surgery, including smaller incisions, reduced postoperative pain, shorter hospital stays, and faster recovery times. Trocars are essential instruments in these procedures, providing the necessary access points for surgical instruments and cameras.
Furthermore, the COVID-19 pandemic has accelerated the adoption of minimally invasive techniques as healthcare systems seek to reduce hospital stays and minimise the risk of infection. This shift has further boosted the demand for trocars and other laparoscopic instruments.
Market Restraint: Risk of trocar-related complications and availability of alternative access devices
Despite the growing adoption of minimally invasive procedures, the risk of trocar-related complications poses a significant restraint to market growth. Trocar injuries, while relatively rare, can lead to serious complications such as vascular or organ damage. These risks can deter some surgeons and healthcare providers from adopting laparoscopic techniques, particularly in complex cases or high-risk patients.
The availability of alternative access devices and techniques also presents a challenge to the trocars market. For example, the development of natural orifice transluminal endoscopic surgery (NOTES) and robotic-assisted surgical systems may reduce the reliance on traditional trocars in certain procedures. While these alternative approaches are still evolving and have limited applications, their continued development could impact the long-term growth of the trocars market.
Disposable Trocars dominate the Trocars market.
Disposable trocars currently hold the largest market share in the trocars segment. These single-use devices have gained popularity due to their reduced risk of cross-contamination, consistent performance, and elimination of reprocessing costs. The dominance of disposable trocars can be attributed to their wide range of applications across various surgical specialities and the growing emphasis on infection control in healthcare settings.
Recent advancements in disposable trocar technology have further solidified their market position. Manufacturers have focused on developing trocars with improved safety features, such as retractable blades and transparent cannulas for enhanced visibility. For instance, the introduction of optical trocars with integrated visualisation systems has significantly improved the safety and ease of trocar insertion.
The growing trend towards ambulatory surgical centres (ASCs) has also contributed to the increasing adoption of disposable trocars. ASCs often prefer single-use devices to streamline their operations and reduce the risk of surgical site infections. A recent market report indicated that disposable trocars accounted for over 65% of the total trocars market revenue in 2023, with this trend expected to continue throughout the forecast period.
Moreover, the COVID-19 pandemic has accelerated the shift towards disposable surgical instruments, including trocars, as healthcare facilities seek to minimise the risk of virus transmission. This trend is likely to have a lasting impact on market dynamics, further driving the growth of the disposable trocars segment.
North America dominates the Trocars Market
North America currently holds the largest market share in the global trocars market, with the United States being the primary contributor to this dominance. The region's leadership can be attributed to several factors, including the high adoption rate of minimally invasive surgical techniques, advanced healthcare infrastructure, and the presence of key market players.
The strong presence of leading medical device manufacturers in North America has significantly contributed to market growth. Companies such as Medtronic plc, Johnson & Johnson, and Applied Medical have their headquarters or significant operations in the region, facilitating rapid product launches and extensive marketing efforts. These companies have also invested heavily in research and development, leading to the introduction of advanced trocar systems tailored to the needs of North American healthcare providers.
Recent market data indicates that the North American trocars market value exceeded $600 million in 2023, with a projected annual growth rate of 5% through 2031. This growth is primarily driven by the increasing number of laparoscopic procedures performed in the region, particularly in the areas of general surgery, gynaecology, and urology.
A key statistic supporting North America's market dominance is the high volume of laparoscopic cholecystectomy performed annually. According to the American College of Surgeons, approximately 750,000 laparoscopic cholecystectomies are performed each year in the United States alone, with each procedure requiring multiple trocars for access.
In terms of country-specific developments, Canada has also contributed significantly to the region's market leadership. The Canadian Agency for Drugs and Technologies in Health (CADTH) has issued several positive recommendations for the use of laparoscopic techniques in various surgical applications, which is expected to drive further adoption of trocars in the country.
The trocars market is characterised by intense competition among key players, with a focus on technological innovation, product differentiation, and strategic partnerships. Market leaders such as Medtronic plc, Johnson & Johnson, and Applied Medical collectively hold a significant market share, leveraging their strong R&D capabilities and extensive distribution networks.
Medtronic plc has maintained its position as a market leader through its comprehensive portfolio of trocars, including the Versaport bladeless trocar system. The company's recent financial reports indicate a 6% year-over-year growth in its minimally invasive therapies group, partly attributed to the strong performance of its surgical innovations segment, which includes trocars.
Johnson & Johnson, through its subsidiary Ethicon, has focused on expanding its market presence through product innovation and strategic acquisitions. The company's Endopath XCEL trocar system has shown strong market performance, particularly in the disposable trocars segment. Johnson & Johnson reported a 5.5% increase in revenue for its surgery division in the latest fiscal year, with advanced surgery products, including trocars, contributing to this growth.
Applied Medical has emphasised innovation in its trocar portfolio, with a particular focus on improving safety features and reducing trocar-related complications. The company's GelPoint advanced access platform, which combines the benefits of single-port and multi-port laparoscopy, has gained traction in the market. While Applied Medical is privately held and does not disclose detailed financial information, industry reports suggest that the company has been steadily gaining market share in the trocars segment.
Emerging players such as ConMed Corporation and B. Braun Melsungen AG are gaining traction in the market with novel trocar designs and materials. These companies are focused on addressing unmet needs in specific surgical applications and expanding their geographical resence in emerging markets.
The competitive landscape is expected to evolve further with the entry of new players and ongoing clinical trials evaluating the efficacy and safety of next-generation trocar systems. Market share dynamics may shift as healthcare providers increasingly prioritise evidence-based selection of trocars for various minimally invasive procedures.
The trocars market is poised for steady growth in the coming years, driven by the increasing adoption of minimally invasive surgical techniques and the growing prevalence of chronic diseases requiring surgical interventions. The market's expansion is further supported by technological advancements that are enhancing the safety and efficacy of trocar systems.
An exclusive trend to watch is the development of smart trocars integrated with sensors and imaging technologies. These advanced devices could provide real-time feedback on tissue layers and anatomical structures during trocar insertion, potentially reducing the risk of complications and improving surgical outcomes. This convergence of medical devices and digital technologies is likely to open new avenues for market growth and provide opportunities for both established players and innovative start-ups.
Medtronic plc
Johnson & Johnson (Ethicon)
Applied Medical
B. Braun Melsungen AG
ConMed Corporation
The Cooper Companies, Inc. (CooperSurgical)
Karl STORZ SE & Co. KG
Teleflex Incorporated
Genicon, Inc.
Purple Surgical International Ltd.
April 2023: Medtronic plc launched its new Versaport™ Lap-X trocar system in Europe, featuring an advanced blade design for improved insertion and reduced tissue trauma.
January 2023: Applied Medical received FDA clearance for its GelPoint Mini+ advanced access platform, designed for single-site laparoscopic procedures in paediatric patients.
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope and Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking—Key Players
3.3. Market Share Analysis -- Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES (Key Companies List by Country) (Premium)
5. COMPANY PROFILES
5.1. Medtronic plc
5.2. Johnson & Johnson (Ethicon)
5.3. Applied Medical
5.4. B. Braun Melsungen AG
5.5. ConMed Corporation
5.6. The Cooper Companies, Inc. (CooperSurgical)
5.7. KARL STORZ SE & Co. KG
5.8. Teleflex Incorporated
5.9. Genicon, Inc.
5.10. Purple Surgical International Ltd. (LIST NOT EXHAUSTIVE)
6. MARKET DYNAMICS
6.1. Market Trends
6.1.1. Shift towards single-port laparoscopic surgery
6.1.2. Development of smart trocars with integrated sensors
6.1.3. Increasing adoption of robotic-assisted minimally invasive surgeries
6.2. Market Drivers
6.2.1. Increasing prevalence of chronic diseases and rising demand for minimally invasive surgical procedures
6.2.2. Technological advancements in trocar design
6.2.3. Growing geriatric population and associated surgical needs
6.3. Market Restraints
6.3.1. Risk of trocar-related complications and availability of alternative access devices
6.3.2. High cost of advanced trocar systems
6.4. Market Opportunities
6.5. Porter's Five Forces Analysis
6.5.1. Threat of New Entrants
6.5.2. Bargaining Power of Buyers/Consumers
6.5.3. Bargaining Power of Suppliers
6.5.4. Threat of Substitute Products
6.5.5. Intensity of Competitive Rivalry
6.6. Supply Chain Analysis
6.7. Value Chain Analysis
6.8. Trade Analysis
6.9. Pricing Analysis
6.10. Regulatory Analysis
6.11. Patent Analysis
6.12. SWOT Analysis
6.13. PESTLE Analysis
7. BY PRODUCT TYPE (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
7.1. Disposable Trocars
7.1.1. Standard disposable trocars
7.1.2. Shielded disposable trocars
7.2. Reusable Trocars
7.2.1. Standard reusable trocars
7.2.2. Shielded reusable trocars
8. BY TIP TYPE (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
8.1. Bladed Trocars
8.2. Bladeless Trocars
8.3. Optical Trocars
9. BY APPLICATION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
9.1. General Surgery
9.1.1. Laparoscopic cholecystectomy
9.1.2. Appendectomy
9.1.3. Hernia repair
9.2. Gynaecological Surgery
9.2.1. Hysterectomy
9.2.2. Ovarian cystectomy
9.3. Urological Surgery
9.3.1. Prostatectomy
9.3.2. Nephrectomy
9.4. Paediatric Surgery
9.5. Others
10. BY END-USER (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
10.1. Hospitals
10.2. Ambulatory Surgical Centres
10.3. Speciality Clinics
11. REGION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
11.1. North America
11.1.1. United States
11.1.2. Canada
11.1.3. Mexico
11.2. South America
11.2.1. Brazil
11.2.2. Argentina
11.2.3. Rest of South America
11.3. Europe
11.3.1. Germany
11.3.2. United Kingdom
11.3.3. France
11.3.4. Italy
11.3.5. Spain
11.3.6. Russia
11.3.7. Rest of Europe
11.4. Asia-Pacific
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia
11.4.5. South Korea
11.4.6. Rest of Asia-Pacific
11.5. Middle-East
11.5.1. UAE
11.5.2. Saudi Arabia
11.5.3. Turkey
11.5.4. Rest of Middle East
11.6. Africa
11.6.1. South Africa
11.6.2. Egypt
11.6.3. Rest of Africa
*NOTE: All the regions mentioned in the scope will be provided with (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%, YOY GROWTH)--2020-2031.
By Product Type:
Disposable Trocars
Reusable Trocars
By Tip Type:
Bladed Trocars
Bladeless Trocars
Optical Trocars
By Application:
General Surgery
Gynaecological Surgery
Urological Surgery
Paediatric Surgery
Others
By End-User:
Hospitals
Ambulatory Surgical Centres
Speciality Clinics
By Region:
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511